TReP-132 is a novel progesterone receptor coactivator required for the inhibition of breast cancer cell growth and enhancement of differentiation by progesterone
about
Cyclin dependent kinase 2 and the regulation of human progesterone receptor activityProgesterone receptor rapid signaling mediates serine 345 phosphorylation and tethering to specificity protein 1 transcription factors.Control of oocyte release by progesterone receptor-regulated gene expression.Progesterone receptor isoform functions in normal breast development and breast cancerCyclin A2 and its associated kinase activity are required for optimal induction of progesterone receptor target genes in breast cancer cellsTdIF1 recognizes a specific DNA sequence through its Helix-Turn-Helix and AT-hook motifs to regulate gene transcription.Evolutionarily emerged G tracts between the polypyrimidine tract and 3' AG are splicing silencers enriched in genes involved in cancer.Progesterone receptor inhibits proliferation of human breast cancer cells via induction of MAPK phosphatase 1 (MKP-1/DUSP1).Intra-tumor heterogeneity in TP53 null High Grade Serous Ovarian Carcinoma progressionEpigenetic Alterations Affecting Transcription Factors and Signaling Pathways in Stromal Cells of EndometriosisProgesterone receptor A and c-Met mediates spheroids-endometrium attachmentProgesterone receptor assembly of a transcriptional complex along with activator protein 1, signal transducer and activator of transcription 3 and ErbB-2 governs breast cancer growth and predicts response to endocrine therapy.GGNBP2 acts as a tumor suppressor by inhibiting estrogen receptor α activity in breast cancer cells.miR-372 and miR-373 enhance the stemness of colorectal cancer cells by repressing differentiation signaling pathways
P2860
Q24678662-2BBACF18-DB83-4DEB-B8FD-29F7FFC46C9EQ33315228-0A26EBFF-240E-4474-BDB4-D4B267DBB8BDQ33595244-0E8D6951-32A5-4BE9-BF8B-933ECC1AEBA8Q33693898-0F65A19B-C2BD-4CC3-BF6C-E7E4A0362014Q34362853-CE1F90D5-E6FA-4FDE-BDC4-298C08E2F66DQ34846495-DAD051D3-E67D-4CD8-943E-7CA621B4161EQ35060560-3D66BB74-61D5-4567-AE8D-57174DAE6167Q35604651-2156B45E-6541-4C40-A89C-3F529FE3E681Q35856294-171EEBD7-E9D6-49E3-90DF-CDAFE429AEACQ36261472-6D42810F-1EB9-4CF6-846D-E563A28E1FFCQ37112310-CD55F1C1-9C52-44EB-B8A1-3C2712909EC4Q37690705-2584D6D3-2162-451F-AA64-D0199272EE74Q38291863-4DC8379B-EC7C-4358-814D-1C7F0E5E3DF5Q58699670-12D2064C-0538-47F8-95A7-497E7B84EF44
P2860
TReP-132 is a novel progesterone receptor coactivator required for the inhibition of breast cancer cell growth and enhancement of differentiation by progesterone
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
TReP-132 is a novel progestero ...... ifferentiation by progesterone
@ast
TReP-132 is a novel progestero ...... ifferentiation by progesterone
@en
TReP-132 is a novel progestero ...... ifferentiation by progesterone
@nl
type
label
TReP-132 is a novel progestero ...... ifferentiation by progesterone
@ast
TReP-132 is a novel progestero ...... ifferentiation by progesterone
@en
TReP-132 is a novel progestero ...... ifferentiation by progesterone
@nl
prefLabel
TReP-132 is a novel progestero ...... ifferentiation by progesterone
@ast
TReP-132 is a novel progestero ...... ifferentiation by progesterone
@en
TReP-132 is a novel progestero ...... ifferentiation by progesterone
@nl
P2093
P2860
P356
P1476
TReP-132 is a novel progestero ...... ifferentiation by progesterone
@en
P2093
Dean W Hum
Florence Gizard
Françoise Révillion
Gérard Torpier
Jean-Philippe Peyrat
Olivier Barbier
Romain Robillard
P2860
P304
P356
10.1128/MCB.00326-06
P407
P577
2006-10-01T00:00:00Z